The global neurovascular microcatheter market size was valued at USD 703.98 million in 2025 and is projected to reach USD 1.22 billion by 2033, growing at a CAGR of 7.07% from 2026 to 2033. The industry is driven by the rising prevalence of neurovascular aneurysms, which is increasing demand for minimally invasive procedures such as coiling and flow diversion, where precise catheter navigation is essential.
In addition, the growing incidence of ischemic stroke is a major factor, as these devices are widely used in mechanical thrombectomy procedures to restore blood flow quickly and effectively. The expanding global burden of stroke, particularly among aging populations, further supports market growth. Moreover, the rising cases of hypertension, a key risk factor for both aneurysms and strokes, are contributing to a larger patient pool requiring neurovascular interventions, thereby boosting the demand for advanced microcatheter technologies and supporting overall market expansion globally.
The rising prevalence of neurovascular aneurysms is growing the market for neurovascular microcatheters, as it significantly increases the demand for minimally invasive treatment procedures. Cerebral aneurysms, if left untreated, can rupture and lead to severe complications such as hemorrhagic stroke, prompting early diagnosis and timely intervention. This has led to an increasing number of endovascular procedures, including coil embolization and flow diversion, where microcatheters are essential for precise navigation through complex cerebral vessels. According to the Hereditary Brain Aneurysm Support 2025, unruptured brain aneurysms, localized bulges or swellings in the brain’s blood vessels, are relatively common, affecting about 3% of the UK population, or roughly 2 million people. While most aneurysms remain asymptomatic and do not cause problems, a small number, between 3,000 and 5,000 cases each year, rupture, with approximately half of these resulting in fatal outcomes. In addition, advancements in imaging technologies and increasing awareness among patients and healthcare providers have improved early detection rates. The shift toward minimally invasive techniques, due to reduced recovery time and lower procedural risks, is further accelerating adoption.
"Brain aneurysms typically produce no symptoms but can burst without warning with catastrophic consequences. The reality is that most brain aneurysms will never rupture, but we currently have no way of identifying the minority that will. We are making great strides in understanding clinical risk factors but our ability to understand the genetics behind their development and understand why they rupture remains surprisingly limited for a condition that potentially impacts 3% of the UK population."- Professor Diederik Bulters, Consultant Neurosurgeon at UHS, Honorary Professor of Neurovascular Surgery at the University of Southampton, and Chief Investigator of the ROAR Study.
The rising prevalence of stroke is growing the market for neurovascular microcatheters, as it significantly increases the need for timely and effective treatment interventions. Ischemic strokes, which account for the majority of cases, require procedures such as mechanical thrombectomy to restore blood flow to the brain quickly. Neurovascular microcatheters play a vital role in these procedures by enabling precise navigation through complex cerebral arteries and supporting accurate device delivery. The increasing incidence of stroke, driven by aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity, is leading to a higher number of interventional procedures. In addition, growing awareness about early stroke management and improved healthcare infrastructure are further boosting the adoption of neurovascular microcatheters, thereby driving market growth.
Technological advancements are driving the neurovascular microcatheter market by significantly improving the performance, safety, and precision of endovascular procedures. Innovations such as enhanced flexibility, smaller diameters, improved trackability, and hydrophilic coatings enable microcatheters to navigate complex, tortuous cerebral vessels with greater ease and accuracy. In 2025, Researchers at EPFL developed an extremely small, highly flexible neurovascular microcatheter that can navigate complex, branching blood vessels with ease. Uniquely, the device is driven by natural blood flow, allowing it to travel quickly and safely through intricate arterial pathways, improving navigation and reducing the risk during neurovascular procedures.
“Catheters eliminate concerns about device removal after use, and don’t have limited payloads. At the same time, many blood vessels lie beyond a traditional catheter’s reach,” Sakar explains. “That’s why we have developed and tested MagFlow: an ultraminiaturized magnetic microcatheter - twice as small as benchmark microcatheters - that minimizes contact with vessel walls by hitching a ride on the blood stream’s own kinetic energy.” - head of the MicroBioRobotic Systems Laboratory in EPFL’s School of Engineering
The development of dual-lumen, steerable microcatheters further enables better control and targeted delivery of therapeutic devices during procedures such as coil embolization and thrombectomy. In addition, integration with advanced imaging systems and real-time navigation technologies enhances procedural outcomes and reduces risks. These continuous improvements are increasing physician confidence, expanding the scope of minimally invasive treatments, and driving the adoption of neurovascular microcatheters across healthcare settings.
This product will be delivered within 1-3 business days.
In addition, the growing incidence of ischemic stroke is a major factor, as these devices are widely used in mechanical thrombectomy procedures to restore blood flow quickly and effectively. The expanding global burden of stroke, particularly among aging populations, further supports market growth. Moreover, the rising cases of hypertension, a key risk factor for both aneurysms and strokes, are contributing to a larger patient pool requiring neurovascular interventions, thereby boosting the demand for advanced microcatheter technologies and supporting overall market expansion globally.
The rising prevalence of neurovascular aneurysms is growing the market for neurovascular microcatheters, as it significantly increases the demand for minimally invasive treatment procedures. Cerebral aneurysms, if left untreated, can rupture and lead to severe complications such as hemorrhagic stroke, prompting early diagnosis and timely intervention. This has led to an increasing number of endovascular procedures, including coil embolization and flow diversion, where microcatheters are essential for precise navigation through complex cerebral vessels. According to the Hereditary Brain Aneurysm Support 2025, unruptured brain aneurysms, localized bulges or swellings in the brain’s blood vessels, are relatively common, affecting about 3% of the UK population, or roughly 2 million people. While most aneurysms remain asymptomatic and do not cause problems, a small number, between 3,000 and 5,000 cases each year, rupture, with approximately half of these resulting in fatal outcomes. In addition, advancements in imaging technologies and increasing awareness among patients and healthcare providers have improved early detection rates. The shift toward minimally invasive techniques, due to reduced recovery time and lower procedural risks, is further accelerating adoption.
"Brain aneurysms typically produce no symptoms but can burst without warning with catastrophic consequences. The reality is that most brain aneurysms will never rupture, but we currently have no way of identifying the minority that will. We are making great strides in understanding clinical risk factors but our ability to understand the genetics behind their development and understand why they rupture remains surprisingly limited for a condition that potentially impacts 3% of the UK population."- Professor Diederik Bulters, Consultant Neurosurgeon at UHS, Honorary Professor of Neurovascular Surgery at the University of Southampton, and Chief Investigator of the ROAR Study.
The rising prevalence of stroke is growing the market for neurovascular microcatheters, as it significantly increases the need for timely and effective treatment interventions. Ischemic strokes, which account for the majority of cases, require procedures such as mechanical thrombectomy to restore blood flow to the brain quickly. Neurovascular microcatheters play a vital role in these procedures by enabling precise navigation through complex cerebral arteries and supporting accurate device delivery. The increasing incidence of stroke, driven by aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity, is leading to a higher number of interventional procedures. In addition, growing awareness about early stroke management and improved healthcare infrastructure are further boosting the adoption of neurovascular microcatheters, thereby driving market growth.
Technological advancements are driving the neurovascular microcatheter market by significantly improving the performance, safety, and precision of endovascular procedures. Innovations such as enhanced flexibility, smaller diameters, improved trackability, and hydrophilic coatings enable microcatheters to navigate complex, tortuous cerebral vessels with greater ease and accuracy. In 2025, Researchers at EPFL developed an extremely small, highly flexible neurovascular microcatheter that can navigate complex, branching blood vessels with ease. Uniquely, the device is driven by natural blood flow, allowing it to travel quickly and safely through intricate arterial pathways, improving navigation and reducing the risk during neurovascular procedures.
“Catheters eliminate concerns about device removal after use, and don’t have limited payloads. At the same time, many blood vessels lie beyond a traditional catheter’s reach,” Sakar explains. “That’s why we have developed and tested MagFlow: an ultraminiaturized magnetic microcatheter - twice as small as benchmark microcatheters - that minimizes contact with vessel walls by hitching a ride on the blood stream’s own kinetic energy.” - head of the MicroBioRobotic Systems Laboratory in EPFL’s School of Engineering
The development of dual-lumen, steerable microcatheters further enables better control and targeted delivery of therapeutic devices during procedures such as coil embolization and thrombectomy. In addition, integration with advanced imaging systems and real-time navigation technologies enhances procedural outcomes and reduces risks. These continuous improvements are increasing physician confidence, expanding the scope of minimally invasive treatments, and driving the adoption of neurovascular microcatheters across healthcare settings.
Global Neurovascular Microcatheter Market Report Segmentation
This report forecasts global, regional, and country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, the analyst has segmented the global neurovascular microcatheter market report on the basis of type, application, end use, and region:Type Outlook (Revenue, USD Million, 2021-2033)
- Single-Lumen Microcatheters
- Dual-Lumen Balloon Microcatheters
Application Outlook (Revenue, USD Million, 2021-2033)
- Diagnostic Delivery
- Therapeutic Embolization Delivery
- Temporary Occlusion / Flow Control
- Vascular Access & Navigation
- Others
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Neurovascular Microcatheter Market Variables, Trends & Scope
Chapter 4. Neurovascular Microcatheter Market: Type (Capacity / Model-Based) Estimates & Trend Analysis
Chapter 5. Neurovascular Microcatheter Market: Application Estimates & Trend Analysis
Chapter 6. Neurovascular Microcatheter Market: End Use Estimates & Trend Analysis
Chapter 7. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis, by Type, by Application, and by End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Stryker
- Medtronic
- MicroVention (Terumo)
- Balt
- Johnson & Johnson (Cerenovus)
- Penumbra (Boston Scientific Corporation)
- Cook Medical
- Merit Medical
- Asahi Intecc
- Integer Holdings
- Acandis GmbH (Lauxera Capital Partners)
- phenox GmbH (Wallaby Medical)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 703.98 Million |
| Forecasted Market Value ( USD | $ 1220 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
